Dr Antonin Serrano
Research Fellow
Department of Clinical Pathology
9 Scholarly works
2 Projects
HIGHLIGHTS
2026
Research grants (other domestic)
Targeting a Novel RNA Processing Pathway for the Treatment of Cancer
2026
Journal article
Genetic barcoding uncovers the clonal makeup of solid and liquid biopsies and their ability to capture intra-tumoral heterogeneity
DOI: 10.1038/s44320-026-00194-w2025
Research grants (other domestic)
Overcoming Pancreatic Cancer Chemoresistance Through Innovative Strategies
2023
Journal article
Experimental and spontaneous metastasis assays can result in divergence in clonal architecture
DOI: 10.1038/s42003-023-05167-52022
Journal article
Mastering the use of cellular barcoding to explore cancer heterogeneity
DOI: 10.1038/s41568-022-00500-22022
Journal article
Computational Screening of Anti-Cancer Drugs Identifies a New BRCA Independent Gene Expression Signature to Predict Breast Cancer Sensitivity to Cisplatin
DOI: 10.3390/cancers141024042022
Thesis / Dissertation
Deciphering breast cancer heterogeneity and metastatic fate using cellular barcoding
RECENT SCHOLARLY WORKS
2021
Journal article
The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile
DOI: 10.1126/sciadv.abf44082019
Journal article
Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer
DOI: 10.1038/s41467-019-08595-22019
Journal article
Publisher Correction: Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer (Nature Communications, (2019), 10, 1, (766), 10.1038/s41467-019-08595-2)
DOI: 10.1038/s41467-019-09916-12017
Journal article
Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer
DOI: 10.1126/scitranslmed.aam7049